HR 6321119th CongressIn Committee
Lung Cancer Medicare Access to Precise Testing Act
Standard Summary
Balanced plain-English summary
This bill would amend the Social Security Act to require Medicare coverage of lung cancer biomarker testing for individuals diagnosed with lung cancer beginning January 1, 2027, and would set payment at 100 percent of reasonable charges for such testing.
Key Points
- 1Requires Medicare coverage for lung cancer biomarker testing.
- 2Defines testing as analysis of tissue, blood, or bodily fluids to identify cancer biomarkers.
- 3Applies to tests furnished on or after January 1, 2027.
- 4Sets Medicare payment at 100 percent of reasonable charges for the testing.
- 5Amends title XVIII of the Social Security Act.
Impact Areas
Medicare beneficiaries with lung cancerOncologists and cancer care providersClinical laboratoriesMedicare programTaxpayers
Generated by deepseek/deepseek-v4.1-flash-1017Nov 18, 2026